Skip to main content

Pharmacopeial Forum Table of Contents

View the current Pharmacopeial Forum (PF) Table of Contents. Forolder PF tables of contents, visit our archive.

Select from the below links to access PF content. A free resource, PF visitors mustcreate a user name and password.

PF 48(1) Table of Contents Publish date: [January 3, 2022]

Proposed Interim Revision Announcements

General Test and Assay Chapter

<89.2> Collagenase II 1-JUL-2022

USP Monograph

Mesalamine Delayed-Release Tablets 1-JUL-2022

In-Process Revision

General Test and Assay Chapter

<3> Topical And Transdermal Drug Products - Product Quality Tests (USPNF 2023 ISSUE 2)

General Information Chapters

<1212> Probe Tack Test (USPNF 2023 ISSUE 2)

<1504> Quality Attributes of Starting Materials for the Chemical Synthesis of Therapeutic Peptides [NEW] (USPNF 2023 ISSUE 2)

<1567> Pyrrolizidine Alkaloids as Contaminants [NEW] (USPNF 2023 ISSUE 2)

<1604> Presentation of Aerodynamic Particle Size Distribution (APSD) Measurement Data for Orally Inhaled Drug Products (USPNF 2023 ISSUE 2)

Reagents, Indicators, and Solutions

Reagent Specifications

L-Cysteine Hydrochloride, Anhydrous (USPNF 2023 ISSUE 2)

Water, DNase/RNase Free [NEW] (USPNF 2023 ISSUE 2)

Proteose peptone [NEW] (USPNF 2023 ISSUE 2)

Rhodamine B (USPNF 2023 ISSUE 2)

Stearic Acid (USPNF 2023 ISSUE 2)

Test Solutions

Tris-EDTA Buffer, pH 8.0 TS [NEW] (USPNF 2023 ISSUE 2)

Starch TS (USPNF 2023 ISSUE 2)

Volumetric Solutions

0.1 N Silver Nitrate VS (USPNF 2023 ISSUE 2)

0.05 N Silver Nitrate VS (USPNF 2023 ISSUE 2)

0.05 M Sodium Arsenite VS (USPNF 2023 ISSUE 2)

Description and Solubility

Description and Solubility (USPNF 2023 ISSUE 2)

USP Monographs

Cannabidiol [NEW] (USPNF 2023 ISSUE 2)

Clobazam [NEW] (USPNF 2023 ISSUE 2)

Clobazam Tablets [NEW] (USPNF 2023 ISSUE 2)

Dobutamine Hydrochloride (USPNF 2023 ISSUE 2)

Dofetilide Capsules [NEW] (USPNF 2023 ISSUE 2)

Erythromycin (USPNF 2023 ISSUE 2)

Hard Gelatin Capsule Shells (USPNF 2023 ISSUE 2)

Guanfacine Hydrochloride (USPNF 2023 ISSUE 2)

Hard Hypromellose Capsule Shells (USPNF 2023 ISSUE 2)

Methadone Hydrochloride (USPNF 2023 ISSUE 2)

Methadone Hydrochloride Injection (USPNF 2023 ISSUE 2)

Metoprolol Succinate Extended-Release Tablets (USPNF 2023 ISSUE 2)

Mycophenolate Mofetil Capsules (USPNF 2023 ISSUE 2)

Mycophenolate Mofetil Tablets (USPNF 2023 ISSUE 2)

Neomycin Sulfate (USPNF 2023 ISSUE 2)

Nortriptyline Hydrochloride Capsules (USPNF 2023 ISSUE 2)

Hard Pullulan Capsule Shells [NEW] (USPNF 2023 ISSUE 2)

Sodium Picosulfate (USPNF 2023 ISSUE 2)

Tetracycline Hydrochloride Ointment (USPNF 2023 ISSUE 2)

Tetracycline Hydrochloride Tablets (USPNF 2023 ISSUE 2)

Tolterodine Tartrate (USPNF 2023 ISSUE 2)

Tolterodine Tartrate Extended-Release Capsules [NEW] (USPNF 2023 ISSUE 2)

Dietary Supplement Monographs

Terminalia chebula Fruit (USPNF 2023 ISSUE 2)

Terminalia chebula Fruit Dry Extract (USPNF 2023 ISSUE 2)

Terminalia chebula Fruit Powder (USPNF 2023 ISSUE 2)

Stimuli to the Revision Process

Analytical Instrument and System (AIS) Qualification, to support Analytical Procedure Validation Over the Life Cycle [NEW]